Skip to content

Clinical trials

Metabolic Diseases trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Country / region: Portugal Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20091
20152
20181
20201
20211
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Escola Superior de Tecnologia da Saúde do Porto2
Ultragenyx Pharmaceutical Inc2
Calcilytix Therapeutics, Inc., a BridgeBio company1
Faculdade de Motricidade Humana1
Ionis Pharmaceuticals, Inc.1
Takeda1
Universidade Nova de Lisboa1
University of Coimbra1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases10
Lysosomal Storage Diseases2
Mucopolysaccharidoses2
Mucopolysaccharidosis VII2
Obesity2
Rare Diseases2
Acute Coronary Syndrome1
Calcium Metabolism Disorders1
Diabetes Mellitus1
Diabetes Mellitus, Type 21

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.